243 related articles for article (PubMed ID: 15812223)
1. Good manufacturing practice production of adenoviral vectors for clinical trials.
Lusky M
Hum Gene Ther; 2005 Mar; 16(3):281-91. PubMed ID: 15812223
[TBL] [Abstract][Full Text] [Related]
2. Large-scale adenovirus and poxvirus-vectored vaccine manufacturing to enable clinical trials.
Kallel H; Kamen AA
Biotechnol J; 2015 May; 10(5):741-7. PubMed ID: 25914340
[TBL] [Abstract][Full Text] [Related]
3. Development and optimization of an adenovirus production process.
Kamen A; Henry O
J Gene Med; 2004 Feb; 6 Suppl 1():S184-92. PubMed ID: 14978761
[TBL] [Abstract][Full Text] [Related]
4. [Producing recombinant adenovirus encoding green fluorescent protein (Ad-GFP) by suspension cultured HEK-293 N3S cells].
Tian B; Wu B; Zhang QW; Bi JJ; Wang L; Zhu BZ; Geng Y; Wu ZZ
Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):915-8. PubMed ID: 18051875
[TBL] [Abstract][Full Text] [Related]
5. Characterization of helper-dependent adenoviral vectors.
Palmer DJ; Ng P
Cold Spring Harb Protoc; 2011 Jul; 2011(7):867-70. PubMed ID: 21724820
[No Abstract] [Full Text] [Related]
6. Rescue, amplification, and large-scale production of helper-dependent adenoviral vectors.
Palmer DJ; Ng P
Cold Spring Harb Protoc; 2011 Jul; 2011(7):857-66. PubMed ID: 21724821
[No Abstract] [Full Text] [Related]
7. Improvements in gene therapy: averting the immune response to adenoviral vectors.
Ritter T; Lehmann M; Volk HD
BioDrugs; 2002; 16(1):3-10. PubMed ID: 11908997
[TBL] [Abstract][Full Text] [Related]
8. Enhanced preparation of adeno-associated viral vectors by using high hydrostatic pressure to selectively inactivate helper adenovirus.
Leonard JN; Ferstl P; Delgado A; Schaffer DV
Biotechnol Bioeng; 2007 Aug; 97(5):1170-9. PubMed ID: 17252611
[TBL] [Abstract][Full Text] [Related]
9. Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3).
Shen CF; Lanthier S; Jacob D; Montes J; Beath A; Beresford A; Kamen A
Vaccine; 2012 Jan; 30(2):300-6. PubMed ID: 22079076
[TBL] [Abstract][Full Text] [Related]
10. Physical and infectious titers of helper-dependent adenoviral vectors: a method of direct comparison to the adenovirus reference material.
Palmer DJ; Ng P
Mol Ther; 2004 Oct; 10(4):792-8. PubMed ID: 15451463
[TBL] [Abstract][Full Text] [Related]
11. Current Use of Adenovirus Vectors and Their Production Methods.
Sayedahmed EE; Kumari R; Mittal SK
Methods Mol Biol; 2019; 1937():155-175. PubMed ID: 30706395
[TBL] [Abstract][Full Text] [Related]
12. Optimization of adenoviral production in human embryonic kidney cells using response surface methodology.
Liu CH; Wu PS
J Biosci Bioeng; 2007 May; 103(5):406-11. PubMed ID: 17609154
[TBL] [Abstract][Full Text] [Related]
13. GMP-Compliant Adenoviral Vectors for Gene Therapy.
Arjmand B; Alavi-Moghadam S; Payab M; Goodarzi P; Sheikh Hosseini M; Tayanloo-Beik A; Rezaei-Tavirani M; Larijani B
Methods Mol Biol; 2021; 2286():237-250. PubMed ID: 32504293
[TBL] [Abstract][Full Text] [Related]
14. Development of a platform process for adenovirus purification that removes human SET and nucleolin and provides high purity vector for gene delivery.
Riske F; Berard N; Albee K; Pan P; Henderson M; Adams K; Godwin S; Spear S
Biotechnol Bioeng; 2013 Mar; 110(3):848-56. PubMed ID: 23042531
[TBL] [Abstract][Full Text] [Related]
15. From the first to the third generation adenoviral vector: what parameters are governing the production yield?
Dormond E; Perrier M; Kamen A
Biotechnol Adv; 2009; 27(2):133-44. PubMed ID: 19013226
[TBL] [Abstract][Full Text] [Related]
16. Scaleable production of adenoviral vectors by transfection of adherent PER.C6 cells.
Subramanian S; Kim JJ; Harding F; Altaras GM; Aunins JG; Zhou W
Biotechnol Prog; 2007; 23(5):1210-7. PubMed ID: 17715941
[TBL] [Abstract][Full Text] [Related]
17. Advancements in the design and scalable production of viral gene transfer vectors.
Sharon D; Kamen A
Biotechnol Bioeng; 2018 Jan; 115(1):25-40. PubMed ID: 28941274
[TBL] [Abstract][Full Text] [Related]
18. An efficient and scalable process for helper-dependent adenoviral vector production using polyethylenimine-adenofection.
Dormond E; Meneses-Acosta A; Jacob D; Durocher Y; Gilbert R; Perrier M; Kamen A
Biotechnol Bioeng; 2009 Feb; 102(3):800-10. PubMed ID: 18821637
[TBL] [Abstract][Full Text] [Related]
19. Scalable production of adenovirus vectors.
Silva AC; Fernandes P; Sousa MF; Alves PM
Methods Mol Biol; 2014; 1089():175-96. PubMed ID: 24132486
[TBL] [Abstract][Full Text] [Related]
20. Manufacturing of adenovirus vectors: production and purification of helper dependent adenovirus.
Dormond E; Kamen AA
Methods Mol Biol; 2011; 737():139-56. PubMed ID: 21590396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
